Group Interpersonal Psychotherapy for Depressed Adolescents in School-based Clinics
NCT ID: NCT00270244
Last Updated: 2011-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
16 participants
INTERVENTIONAL
2005-12-31
2008-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in this 16-week single-blind study will be randomly assigned to receive either IPT-AG or TAU in a school-based clinic. Participants assigned to receive IPT-AG will attend two to three, 40-minute individual pre-group sessions, followed by 12, 90-minute group therapy sessions and two additional individual sessions-one midway through the group sessions and another upon completion of group therapy. TAU will consist of counseling sessions as regularly conducted by the school clinic social worker and/or referral to another agency. Study visits will occur at baseline and Weeks 4, 8, 12, and 16, or upon early termination. At the end of 16 weeks, participants assigned to receive IPT-AG will continue in a maintenance program in which they will receive IPT-AG once a month for an additional 6 months. All participants will also be assessed 6 and 12 months post-treatment to measure depressive symptoms, global and social functioning, satisfaction with care, and utilization of other services.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Participants will receive treatment as usual
Treatment as usual (TAU)
TAU will consist of counseling sessions as regularly conducted by the school clinic social worker and/or referral to another agency.
2
Participants will receive group interpersonal psychotherapy for depressed adolescents
Group interpersonal psychotherapy for depressed adolescents (IPT-AG)
Participants assigned to IPT-AG will attend two to three, 40-minute individual pre-group sessions, followed by 12, 90-minute group therapy sessions and two additional individual sessions-one midway through the group sessions and another upon completion of group therapy. Sessions will focus on problems in interpersonal relationships.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group interpersonal psychotherapy for depressed adolescents (IPT-AG)
Participants assigned to IPT-AG will attend two to three, 40-minute individual pre-group sessions, followed by 12, 90-minute group therapy sessions and two additional individual sessions-one midway through the group sessions and another upon completion of group therapy. Sessions will focus on problems in interpersonal relationships.
Treatment as usual (TAU)
TAU will consist of counseling sessions as regularly conducted by the school clinic social worker and/or referral to another agency.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Score of 24 or greater on the CES-D
* Score between 10 and 28 on the HRSD
* Score of 65 or less on the C-GAS
* English-speaking
* Parental or legal guardian consent to participate
Exclusion Criteria
* Score greater than 28 on the HRSD
* Mentally retarded
* Any life threatening medical illness
* Meets diagnostic criteria for current substance abuse, schizophrenia, or bipolar disorder
* Any evidence of psychosis, conduct disorder, or active eating disorder
* Currently in active treatment for depression
* Taking antidepressant medication at the time of baseline assessment
* Recent death of someone close
12 Years
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
New York State Psychiatric Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura H. Mufson, PhD
Role: PRINCIPAL_INVESTIGATOR
New York State Psychiatric Institute-Columbia University College of Physicians and Surgeons
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DSIR 84-CTS
Identifier Type: -
Identifier Source: secondary_id
R01 MH73640, #5037
Identifier Type: -
Identifier Source: org_study_id